on BASTIDE (EPA:BLC)
Sustained Growth for Bastide in the 3rd Quarter of 2024-2025
The Bastide Group reported revenue of €144.2 million for the third quarter of 2024-2025, representing organic growth of 7.7%. This momentum is driven by home healthcare services, particularly in the Respiratory and Nutrition-Infusion-Stoma Therapy segments, which posted increases of 10.4% and 7.3% respectively.
Over a nine-month period, revenue reached €419.4 million, representing an 8.4% increase compared to the previous year. Home care also contributed, with revenue of €150.8 million, up 4.2%.
These results allow the group to confirm its objectives for 2024-2025, with a targeted turnover of at least €560 million and an operating margin of 9.1% or more. Strict management of working capital requirements and investments is a lever for improving its debt ratios.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news